Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1 to 10 of 2483

TitleReference numberPublishedLast updated
Mirikizumab for treating moderately to severely active Crohn's diseaseTA1080
Zanubrutinib for treating relapsed or refractory mantle cell lymphomaTA1081
One-piece closed bags for colostomies: late-stage assessmentHTE29
Pulsed-field ablation for atrial fibrillationIPG806
Intermittent urethral catheters for chronic incomplete bladder emptying in adults: late-stage assessmentHTE28
Dapagliflozin for treating chronic kidney diseaseTA1075
Adagrasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancer (terminated appraisal)TA1076
Nemolizumab for treating moderate to severe atopic dermatitis in people 12 years and overTA1077
Fosdenopterin for treating molybdenum cofactor deficiency type A (terminated appraisal)TA1078
Sparsentan for treating primary IgA nephropathyTA1074

Results per page

  1. 10
  2. 25
  3. 50
  4. All